Lisa Mogelnicki, DPM
Podiatrist · Tulsa, OKNPI 1689967739
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,423 of the $2,258 with a category attached, or 63.0%. 12 manufacturers reported payments, led by Stryker at 52.9% of the total. Reporting peaked in 2024 at $1,159 and has fallen 90.1% since, to $115 in 2025.
Across 43 payments — averaging $52.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Trice Medical, Inc.$340
- Smith+Nephew$225
- Johnson & Johnson$123
- Tenex Health Inc.$107
- Organogenesis Inc.$65
- plus $205 from 6 others
What the payments were for
- Travel & lodging$83537%
- Food & beverage$1,42363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 10 | $1,194 |
| Trice Medical, Inc. | 2 | $340 |
| Smith+Nephew | 17 | $225 |
| Johnson & Johnson | 1 | $123 |
| Tenex Health Inc. | 1 | $107 |
| Organogenesis Inc. | 3 | $65 |
| Heron Therapeutics, Inc. | 2 | $50 |
| Mimedx Group, Inc. | 2 | $43 |
| Averitas Pharma Inc. | 2 | $42 |
| Pylant Medical | 1 | $26 |
| Acera Surgical, Inc. | 1 | $23 |
| Polynovo North America LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,258 in reported general payments places this provider in the 60th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 15 | $9,145 |
| Terbinafine Hcl | 119 | $1,158 |
| Nabumetone | 79 | $1,016 |
| Doxycycline Hyclate | 183 | $953 |
| Ciclopirox | 30 | $888 |
| Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12) | 31 | $710 |
| Gabapentin | 136 | $670 |
| Ketoconazole | 49 | $638 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 60 | $471 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 51 | $381 |
| Clindamycin Hcl | 43 | $351 |
| Methylprednisolone | 38 | $335 |
| Ciprofloxacin Hcl | 48 | $327 |
| Duloxetine Hcl | 11 | $314 |
| Celecoxib | 30 | $269 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $225 | $9,14515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 54 podiatrist providers in Oklahoma.
Other podiatrist in Tulsa
- Kevin QuangTulsa$3K
- Robert LeeTulsa$2K
- Mark NahmiasTulsa$1K
- Lauren GiddensTulsa$861
- Allison IskiTulsa$666
- Timothy MaclinTulsa$360
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Aerial AveryAda$13K
- Patricia BoehleOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.